Citation Impact
Citing Papers
The IκB-NF-κB Signaling Module: Temporal Control and Selective Gene Activation
2002 StandoutScienceNobel
Strategy for Dual-Analyte Luciferin Imaging: In Vivo Bioluminescence Detection of Hydrogen Peroxide and Caspase Activity in a Murine Model of Acute Inflammation
2013 StandoutNobel
NF-κB to the rescue: RELs, apoptosis and cellular transformation
1999
Her-2/neu overexpression induces NF-κB via a PI3-kinase/Akt pathway involving calpain-mediated degradation of IκB-α that can be inhibited by the tumor suppressor PTEN
2001
Down-Regulation of Na+/K+ATPase Activity by Human Parvovirus B19 Capsid Protein VP1
2013 Standout
Serum- and Polypeptide Growth Factor-Inducible Gene Expression in Mouse Fibroblasts
1997
Activators and target genes of Rel/NF-κB transcription factors
1999 Standout
The aryl hydrocarbon receptor links TH17-cell-mediated autoimmunity to environmental toxins
2008 StandoutNature
Inflammation and metabolic disorders
2006 StandoutNature
NF-κB Inhibits Apoptosis in Murine Mammary Epithelia
2000
Signaling through the antigen receptor of B lymphocytes activates a p53-independent pathway of c-Myc-induced apoptosis
1999 StandoutNobel
Epithelial-Mesenchymal Transitions in Development and Disease
2009 Standout
NF-κB in breast cancer cells promotes osteolytic bone metastasis by inducing osteoclastogenesis via GM-CSF
2006
NF-κB is essential for epithelial-mesenchymal transition and metastasis in a model of breast cancer progression
2004
High susceptibility to bacterial infection, but no liver dysfunction, in mice compromised for hepatocyte NF-κB activation
2000
NF-κB in cancer: from innocent bystander to major culprit
2002 Standout
Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined Factors
2006 StandoutNobel
Control of oncogenesis and cancer therapy resistance by the transcription factor NF-κB
2001
The transcription factor NF-κB: control of oncogenesis and cancer therapy resistance
2000
Overexpression of urokinase-type plasminogen activator in pancreatic adenocarcinoma is regulated by constitutively activated RelA
1999
NF-κB subunit p65 binds to 53BP2 and inhibits cell death induced by 53BP2
1999
Constitutive nuclear factor-kappaB-RelA activation is required for proliferation and survival of Hodgkin's disease tumor cells.
1997
Induction of IκBα Expression as a Mechanism Contributing to the Anti-inflammatory Activities of Peroxisome Proliferator-activated Receptor-α Activators
2000
Selective activation of NF-κB subunits in human breast cancer: potential roles for NF-κB2/p52 and for Bcl-3
2000
Medulloblastoma Growth Inhibition by Hedgehog Pathway Blockade
2002 StandoutScience
Inhibition of Interleukin-1-stimulated NF-κB RelA/p65 Phosphorylation by Mesalamine Is Accompanied by Decreased Transcriptional Activity
1999
Thioredoxin-like 2 regulates human cancer cell growth and metastasis via redox homeostasis and NF-κB signaling
2010
Nuclear factor-κB in cancer development and progression
2006 StandoutNature
Activation of NF-kappaB/Rel occurs early during neoplastic transformation of mammary cells
2000
Müllerian Inhibiting Substance Inhibits Breast Cancer Cell Growth through an NFκB-mediated Pathway
2000
Sulindac Inhibits Activation of the NF-κB Pathway
1999
Q-VD-OPh, a broad spectrum caspase inhibitor with potent antiapoptotic properties
2003
OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis
1999 StandoutNature
Osteoclast differentiation and activation
2003 StandoutNature
Essential role of caspases in epigallocatechin-3-gallate-mediated inhibition of nuclear factor kappaB and induction of apoptosis
2003
Tyrosine phosphorylation‐dependent activation of NF‐κB
2001
Oxidants, oxidative stress and the biology of ageing
2000 StandoutNature
NF-κB in cancer: a marked target
2003
Imaging Dynamic Redox Changes in Mammalian Cells with Green Fluorescent Protein Indicators
2004 StandoutNobel
Requirement for NF-κB in osteoclast and B-cell development
1997
A model for p53-induced apoptosis
1997 StandoutNature
Origin and physiological roles of inflammation
2008 StandoutNature
NF-κB and cell-cycle regulation: the cyclin connection
2001
Nuclear factor-κB is upregulated in colorectal cancer
2001
Molecular mechanisms of constitutive NF-κB/Rel activation in Hodgkin/Reed-Sternberg cells
1999
NF-κB functions as a tumour promoter in inflammation-associated cancer
2004 StandoutNature
The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1
1996 StandoutNature
IKKα Provides an Essential Link between RANK Signaling and Cyclin D1 Expression during Mammary Gland Development
2001
Apoptosis: Activate NF-κB or die?
1997
A requirement for NF-kappa B activation in Bcr-Abl-mediated transformation
1998
NF-κB is a target of AKT in anti-apoptotic PDGF signalling
1999 StandoutNature
Homocysteine and Atherothrombosis
1998 Standout
Bifidobacteria can protect from enteropathogenic infection through production of acetate
2011 StandoutNature
Endoplasmic Reticulum Stress Signaling in Disease
2006
Role of YAP/TAZ in mechanotransduction
2011 StandoutNature
Bcl10 Is Involved in t(1;14)(p22;q32) of MALT B Cell Lymphoma and Mutated in Multiple Tumor Types
1999
Impaired apoptosis, extended duration of immune responses, and a lupus-like autoimmune disease in IEX-1-transgenic mice
2002 StandoutNobel
Discrete changes of cell membrane capacitance observed under conditions of enhanced secretion in bovine adrenal chromaffin cells.
1982 StandoutNobel
β-Arrestin inhibits NF-κB activity by means of its interaction with the NF-κB inhibitor IκBα
2004 StandoutNobel
Extracellular matrix alters PDGF regulation of fibroblast integrins.
1996
Reactive oxygen species are downstream mediators of p53-dependent apoptosis.
1996
Proteasome regulation of activation-induced T cell death
1997 StandoutNobel
Human Parvovirus B19 Nonstructural (NS1) Protein Induces Apoptosis in Erythroid Lineage Cells
1998 Standout
The nuclear factor kappa B (NF-κB): A potential therapeutic target for estrogen receptor negative breast cancers
2001
The Transcriptional Program in the Response of Human Fibroblasts to Serum
1999 StandoutScience
Constitutive Activation of Toll-Mediated Antifungal Defense in Serpin-Deficient Drosophila
1999 StandoutScienceNobel
Bone Resorption by Osteoclasts
2000 StandoutScience
NF-κB is essential for epithelial-mesenchymal transition and metastasis in a model of breast cancer progression
2004
Posttranslational hydroxylation of ankyrin repeats in IκB proteins by the hypoxia-inducible factor (HIF) asparaginyl hydroxylase, factor inhibiting HIF (FIH)
2006 StandoutNobel
Spatial distribution of calcium channels and cytosolic calcium transients in growth cones and cell bodies of sympathetic neurons.
1988 StandoutNobel
Cancer Immunoediting: Integrating Immunity’s Roles in Cancer Suppression and Promotion
2011 StandoutScience
Experimental Autoimmune Encephalomyelitis in NF-κB- Deficient Mice: Roles of NF-κB in the Activation and Differentiation of Autoreactive T Cells
1999
RelB/p52 NF-κB Complexes Rescue an Early Delay in Mammary Gland Development in Transgenic Mice with Targeted Superrepressor IκB-α Expression and Promote Carcinogenesis of the Mammary Gland
2005
NF-κB Antiapoptosis: Induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to Suppress Caspase-8 Activation
1998 StandoutScience
Bcl-2-mediated alterations in endoplasmic reticulum Ca 2+ analyzed with an improved genetically encoded fluorescent sensor
2004 StandoutNobel
Activation of a potassium current by rapid photochemically generated step increases of intracellular calcium in rat sympathetic neurons.
1987 StandoutNobel
Wound Healing--Aiming for Perfect Skin Regeneration
1997 StandoutScience
Spermidine in health and disease
2018 StandoutScience
Intracellular calcium dependence of large dense-core vesicle exocytosis in the absence of synaptotagmin I
2001 StandoutNobel
Constitutive Activation of NF-κB during Progression of Breast Cancer to Hormone-Independent Growth
1997
Regulation of apoptosis by the circadian clock through NF-κB signaling
2011 StandoutNobel
NF-κB inhibition causes spontaneous apoptosis in Epstein–Barr virus-transformed lymphoblastoid cells
2000
The Myc/Max/Mad Network and the Transcriptional Control of Cell Behavior
2000
IEX -1L, an Apoptosis Inhibitor Involved in NF-κB-Mediated Cell Survival
1998 Science
NF-κB AND REL PROTEINS: Evolutionarily Conserved Mediators of Immune Responses
1998 Standout
NF-κB Function in Growth Control: Regulation of Cyclin D1 Expression and G0/G1-to-S-Phase Transition
1999
Ion channels in synaptic vesicles from Torpedo electric organ.
1988 StandoutNobel
Permanent occupancy of the human immunodeficiency virus type 1 enhancer by NF-kappa B is needed for persistent viral replication in monocytes
1996
Transcriptional Cross Talk between NF-κB and p53
1999
The c-Myc Transactivation Domain Is a Direct Modulator of Apoptotic versus Proliferative Signals
2000
NF-κB Controls Cell Growth and Differentiation through Transcriptional Regulation of Cyclin D1
1999
Roles of IKK kinases and protein kinase CK2 in activation of nuclear factor-kappaB in breast cancer.
2001
The growth cones of Aplysia sensory neurons: Modulation by serotonin of action potential duration and single potassium channel currents
1986 StandoutNobel
Chemotherapy triggers HIF-1–dependent glutathione synthesis and copper chelation that induces the breast cancer stem cell phenotype
2015 StandoutNobel
Voltage dependence of K + channels in guard-cell protoplasts
1987 StandoutNobel
IKK-1 and IKK-2: Cytokine-Activated IκB Kinases Essential for NF-κB Activation
1997 StandoutScience
THE UBIQUITIN SYSTEM
1998 StandoutNobel
Free Radicals in the Physiological Control of Cell Function
2002 Standout
Scanning the human proteome for calmodulin-binding proteins
2005 StandoutNobel
Experimental autoimmune encephalomyelitis in NF-kappa B-deficient mice:roles of NF-kappa B in the activation and differentiation of autoreactive T cells.
1999
Dynamic FoxO transcription factors
2007
Works of Robert E. Bellas being referenced
Differential effects of the widely expressed dMax splice variant of Max on E-box vs initiator element-mediated regulation by c-Myc
1999
Aberrant nuclear factor-kappaB/Rel expression and the pathogenesis of breast cancer.
1997
Expression of a constitutive NF-kappa B-like activity is essential for proliferation of cultured bovine vascular smooth muscle cells.
1995
Inhibition of c-myc Expression Induces Apoptosis of WEHI 231 Murine B Cells
1996
Epidermal growth factor activation of vinculin and beta 1-integrin gene transcription in quiescent Swiss 3T3 cells. Regulation through a protein kinase C-independent pathway
1991
Inhibition of NF-kappa B activity induces apoptosis in murine hepatocytes.
1997
The NF-kappa B binding site is necessary for efficient replication of simian immunodeficiency virus of macaques in primary macrophages but not in T cells in vitro
1993
Inhibition of NF-kappaB/Rel induces apoptosis of murine B cells.
1996
Increased p27Kip1 Cyclin-Dependent Kinase Inhibitor Gene Expression Following Anti-IgM Treatment Promotes Apoptosis of WEHI 231 B Cells
1999